Literature DB >> 20708546

Molecular tools: biology, prognosis, and therapeutic triage.

Ingeborg Fischer1, Kenneth Aldape.   

Abstract

Diffuse gliomas in adults continue to have a dismal prognosis with the current standard therapeutic methods, including maximal surgical resection, radiation, and chemotherapy. The pathogenesis of adult glioma is complex, involving the loss of function of tumor suppressor genes and activation of oncogenes, which are involved in a network of interconnected signaling pathways. Through activation of these pathways, characteristics of malignant gliomas, including uncontrolled proliferation and growth, invasion, and angiogenesis, are driven. Evolving therapeutic approaches are focused on specifically targeting these genetic lesions. This content gives an overview of the current knowledge about the pathogenesis of adult diffuse gliomas, emphasizing new targeted treatment approaches. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708546     DOI: 10.1016/j.nic.2010.05.004

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  4 in total

1.  Radiologic image-based statistical shape analysis of brain tumours.

Authors:  Karthik Bharath; Sebastian Kurtek; Arvind Rao; Veerabhadran Baladandayuthapani
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-03-15       Impact factor: 1.864

2.  Glioma targeting peptide in combination with the P53 C terminus inhibits glioma cell proliferation in vitro.

Authors:  Dan Wang; Meihua Guo; Jiawen Yu; Xinying Wang; Qian Zhang; Xu Yang; Jiaqi Li; Chunhui Zhao; Bin Feng
Journal:  Cytotechnology       Date:  2017-09-06       Impact factor: 2.058

Review 3.  Gene markers in brain tumors: what the epileptologist should know.

Authors:  Quinn Ostrom; Mark L Cohen; Annie Ondracek; Andrew Sloan; Jill Barnholtz-Sloan
Journal:  Epilepsia       Date:  2013-12       Impact factor: 5.864

4.  Emerging biomarkers in glioblastoma.

Authors:  Mairéad G McNamara; Solmaz Sahebjam; Warren P Mason
Journal:  Cancers (Basel)       Date:  2013-08-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.